Early Stage & BD

Early pricing and access insights for pipeline and BD teams

Make confident early pricing and access decisions when data is limited and timelines are tight. Nuro helps early access and BD teams assess pricing potential, payer risk, and evidence gaps at speed. Get structured, repeatable insights to support pipeline strategy and business development decisions.

Built for Early Access and BD Leaders

Designed for Directors and Heads of Early Value and Access, Pricing, and BD Strategy.
If you support early pipeline or BD evaluations, you are expected to deliver clear answers to leadership, often with incomplete data. You need early pricing insights that are fast, credible, and easy to explain.

The Early Access Challenge

Early access and BD teams often face:

Fragmented early data

Pricing benchmarks, analogue data, and payer insights spread across spreadsheets and slides.

Inconsistent early pricing assessments

One-off models that are difficult to update or reuse across assets.

Limited visibility into payer risk

Evidence gaps and HTA expectations identified too late to influence strategy.

High internal scrutiny

Early pricing and access recommendations must be transparent and defensible.

The results

Teams using Nuro achieve:

Faster early pricing assessments

Greater confidence in BD and pipeline decisions

More consistent and transparent early-stage evaluations

Access Infinity is trusted by pharma and biotech teams to support early access strategy across pipeline and BD portfolios.

Time to call in the reinforcements

Unlock your superpowers and be the hero your company needs.